Jiawei Xu
-
- Cancer-related molecular mechanisms research 5
-
- IL-33, ST2, and ILC Pathways 7
-
- Asthma and respiratory diseases 7
-
- Epigenetics and DNA Methylation 7
- Genomics, phytochemicals, and oxidative stress 5
-
- Neonatal Respiratory Health Research 6
-
- Autophagy in Disease and Therapy 5
-
- Childhood Cancer Survivors' Quality of Life 4
- Co-authors
- Liang DongJiping ZhaoJinxiang WuChuanshu HuangTian LiuYahui LiuJintao ZhangDong Zhang
- Cited by
- Cancer ResearchImmunologyPhysiology
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Jiawei Xu
72 papers receiving 863 citations
Peers
Comparison fields: 5 of 96
- Cancer Research 150
- Immunology 172
- Physiology 169
- Molecular Biology 370
- Pulmonary and Respiratory Medicine 157
Countries citing papers authored by Jiawei Xu
This map shows the geographic impact of Jiawei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiawei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiawei Xu more than expected).
Fields of papers citing papers by Jiawei Xu
This network shows the impact of papers produced by Jiawei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiawei Xu. The network helps show where Jiawei Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jiawei Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 1 | |
| 5 | 2025 | 1 | |
| 6 | 2025 | 0 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 1 | |
| 10 | 2024 | 6 | |
| 11 | 2024 | 14 | |
| 12 | 2024 | 0 | |
| 13 | 2023 | 2 | |
| 14 | 2023 | 3 | |
| 15 | 2023 | 5 | |
| 16 | 2022 | 2 | |
| 17 | 2022 | 4 | |
| 18 | 2021 | 4 | |
| 19 | 2021 | 3 | |
| 20 | 2021 | 44 |
About Jiawei Xu
Jiawei Xu is a scholar working on Cancer Research, Immunology and Oncology, having authored 81 papers that have together received 869 indexed citations. Recurring topics across this work include IL-33, ST2, and ILC Pathways (7 papers), Epigenetics and DNA Methylation (7 papers), Asthma and respiratory diseases (7 papers), Neonatal Respiratory Health Research (6 papers), Genomics, phytochemicals, and oxidative stress (5 papers), Cancer-related molecular mechanisms research (5 papers), Autophagy in Disease and Therapy (5 papers) and Childhood Cancer Survivors' Quality of Life (4 papers). The work is most often cited by research in Cancer Research (150 citations), Immunology (172 citations) and Physiology (169 citations). Jiawei Xu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Liang Dong, Jiping Zhao, Jinxiang Wu, Chuanshu Huang, Tian Liu, Yahui Liu, Jintao Zhang, Dong Zhang, Junfei Wang and Jingxia Li. Their work appears in journals such as Brain, Oncogene and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.